Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) is a bioactive nanocomplex derived from bovine milk protein (casein), primarily utilized as a remineralizing agent in preventative dentistry [1]. The complex consists of casein phosphopeptides (CPPs) that contain clusters of phosphoserine residues, which bind and stabilize calcium and phosphate ions in an amorphous, non-crystalline state (ACP), preventing their precipitation into insoluble forms [2]. When introduced into the oral cavity via pastes, gums, or varnishes, CPP-ACP adheres to the dental pellicle and biofilm, serving as a localized reservoir of bioavailable minerals [3]. During acid challenges caused by cariogenic bacteria, the complex releases these ions into the subsurface enamel, maintaining a state of supersaturation that drives the remineralization of early-stage 'white spot' lesions and inhibits further demineralization [4]. Beyond its role in caries management, CPP-ACP is used to treat dentin hypersensitivity and dental erosion, though it is strictly contraindicated for individuals with a confirmed allergy to milk proteins [2][5].
The mechanism involves the stabilization of calcium and phosphate ions by casein phosphopeptides, which prevent these minerals from forming crystalline hydroxyapatite prematurely. These complexes bind to the tooth surface and dental plaque, creating a high-concentration reservoir of bioavailable ions. When the pH of the oral environment drops, the complex releases calcium and phosphate to maintain a supersaturated state relative to tooth mineral, thereby facilitating the diffusion of ions into subsurface lesions to promote remineralization and neutralize plaque acidity.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) (CPP-ACP).